MedPath

To study effectiveness of HD-tDCS in young onset addictive behaviours

Phase 3
Conditions
Health Condition 1: F638- Other impulse disorders
Registration Number
CTRI/2023/08/056081
Lead Sponsor
Central Institute of Psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Children and adolescents scoring above >=2 on Brief screener for Substance and Behavioural Addictions (SSBA, Schluter et al., 2020) 2.Both gender from 10 years to less than 20 years of age. 3.Right-handed 4.Children and adolescents providing assent/consent and written informed consent providing by parents/caregivers for the study.

Exclusion Criteria

1.Children and adolescents with history of chronic or other significant general medical/ neurological Illness. 2.Children and adolescents with history of any psychosis.

3.Children and adolescents with co morbid moderate to severe disorder of intellectual development as diagnosed using Diagnostic Criteria for Research (DCR) of International Classification of Disease-11th edition (ICD-11, World Health Organization,2022) 4.Children and adolescents with co morbid autism spectrum disorder as diagnosed using Diagnostic Criteria for Research (DCR) of International Classification of Disease-11th edition (ICD-11, World Health Organization,2022). 5.Children and adolescents who had prior exposure to any mode of brain stimulation in last 6 months. 6.Having any metallic implants/parts in body 7.Colour blind

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in executive functions & decision making and impulsivity in children adolescents with addictive behaviours after application of HDtDCS as assessed by reduction in scores of Baratts impulsivity scale and The problem solving inventory and Behaviour rating inventory of executive functions self report form and Clinical global impression scale at baseline, 2 and 6 weeks.Timepoint: Improvement in executive functions & decision making and impulsivity in children and adolescents with addictive behaviours after application of HDtDCS as assessed by reduction in scores of Baratts impulsivity scale and The problem solving inventory and behaviour rating inventory of executive functions self report form and Clinical global impression scale at baseline, 2 weeks and 6 weeks.
Secondary Outcome Measures
NameTimeMethod
Changes in BOLD activation of prefrontal cortex using cognitive task & change in resting state functional connectivity after HDtDCS treatment as assessed by fMRI at baseline & 2 weeks.Timepoint: Changes in BOLD activation of prefrontal cortex using cognitive task & change in resting state functional connectivity after HDtDCS treatment as assessed by fMRI at baseline & 2 weeks.
© Copyright 2025. All Rights Reserved by MedPath